Testosterone supplements are not universally safe or dangerous. The answer depends entirely on what type of product you’re using, whether you have a genuine medical need, and how closely your levels are monitored. Prescription testosterone therapy carries real but manageable risks when used under medical supervision for diagnosed low testosterone. Over-the-counter “testosterone boosters,” on the other hand, are largely unregulated and can contain hidden ingredients that pose serious health threats.
OTC Boosters vs. Prescription Testosterone
This distinction matters more than anything else in the safety conversation. Prescription testosterone is a regulated pharmaceutical product with decades of clinical data behind it. The FDA has approved it specifically for men who have low testosterone levels confirmed by blood tests along with an associated medical condition, such as genetic problems affecting the testicles or damage to the brain structures (the hypothalamus and pituitary) that control testosterone production. Notably, the FDA has not approved testosterone products for men whose levels are simply on the lower end of normal or declining with age.
Over-the-counter “testosterone boosters” are a different category entirely. These are marketed as dietary supplements, which means they don’t go through the same rigorous approval process as prescription drugs. The FDA has repeatedly found hidden pharmaceutical ingredients in products sold as natural testosterone boosters. One product, T-Xtra Strength Test Booster, was found to contain tadalafil, the active ingredient in Cialis. That undeclared ingredient can interact with common heart medications called nitrates and drop blood pressure to dangerous levels. The FDA has stated openly that it cannot test and identify all supplements with potentially harmful hidden ingredients. If you’re considering an OTC booster, the regulatory gap alone is a significant safety concern.
Heart and Cardiovascular Risks
Cardiovascular safety has been the biggest question surrounding testosterone therapy for years. The largest trial to date, called TRAVERSE, followed 5,198 men for an average of 22 months. The headline finding: testosterone therapy was “noninferior to placebo” for major adverse cardiac events, meaning it didn’t cause significantly more heart attacks or strokes than a sugar pill. That sounds reassuring, but context matters. More than 60% of participants stopped treatment before the trial ended, and the average treatment period was under two years. Earlier studies had suggested harm, including more cardiovascular events and greater progression of arterial plaque buildup in men randomized to testosterone.
The delivery method also affects cardiovascular risk. A study from UNC found that testosterone injections carry a higher short-term risk of cardiovascular events, stroke, hospitalization, and death compared to gels or patches. Injections cause spikes of abnormally high testosterone levels, while topical options produce more gradual, sustained increases. The risk profiles of patches and gels were similar to each other and consistently lower than injections across multiple study populations.
Blood Thickening: The Hematocrit Issue
One of the most common and measurable side effects of testosterone therapy is erythrocytosis, a condition where your body produces too many red blood cells. This thickens the blood and can increase the risk of blood clots, deep vein thrombosis, and cardiovascular events. Clinical guidelines set a clear threshold: if your hematocrit (the percentage of your blood made up of red blood cells) rises above 54%, your dose needs to be reduced or therapy stopped entirely.
In the TRAVERSE trial, fewer than 1% of participants on the lowest gel dose exceeded that 54% threshold and had to discontinue treatment. But this is exactly why regular blood monitoring is a non-negotiable part of safe testosterone use. Without it, hematocrit can creep up unnoticed.
Prostate Cancer Concerns
For decades, the assumption was that testosterone fuels prostate cancer growth, making therapy risky for any man concerned about his prostate. Current evidence tells a more nuanced story. Multiple studies of older men with low testosterone who received therapy found no higher rates of prostate cancer compared to untreated men. Even among men who were previously treated for prostate cancer and showed no signs of recurrence, testosterone therapy didn’t appear to increase the risk of the cancer returning.
The working explanation is called the saturation model. Prostate cancer cells need testosterone to grow, but only up to a certain level. Once that threshold is reached, additional testosterone doesn’t make a meaningful difference. What does happen in some cases is that testosterone therapy raises PSA levels (a protein used to screen for prostate cancer). Higher PSA readings lead to more biopsies, which can detect cancers that might have gone unnoticed otherwise. So testosterone may increase cancer detection without actually increasing cancer occurrence.
Sleep Apnea and Breathing
If you already have obstructive sleep apnea, testosterone therapy can make it worse. Clinical guidelines generally consider untreated or severe sleep apnea a contraindication for starting testosterone. The mechanisms are still being studied, but testosterone appears to affect the upper airway in ways that increase its tendency to collapse during sleep. It may also alter the body’s chemical signaling for breathing, reducing the stability of normal breathing patterns during rest.
There’s also an indirect connection through the blood-thickening effect. Sleep apnea itself is a risk factor for producing too many red blood cells, and testosterone therapy can compound that problem. If you snore heavily, wake up gasping, or feel excessively tired during the day, getting screened for sleep apnea before starting testosterone is important.
Body Composition and Bone Density
On the benefit side, testosterone therapy reliably changes body composition. In clinical studies, patients gain lean muscle mass and lose body fat. One longitudinal study found that fat-free mass increased by about 6.2 kilograms over 12 months, while the percentage of body fat dropped by roughly 7%. These changes can be meaningful for men with very low testosterone who experience muscle wasting or persistent fatigue.
Testosterone also supports bone mineral density. For men with genuinely low levels, therapy can help reverse the bone thinning that comes with testosterone deficiency. This matters most for older men, who face increasing fracture risk as bone density declines.
How Diagnosis and Monitoring Work
Safe testosterone use starts with proper diagnosis. The Endocrine Society recommends confirming low testosterone through at least two separate blood draws taken in the morning while fasting, since testosterone levels fluctuate throughout the day and drop after eating. Both symptoms (low energy, reduced sex drive, loss of muscle mass) and consistently low blood levels need to be present for a diagnosis of hypogonadism.
Once on therapy, regular monitoring is what separates safe use from risky use. Blood work should track testosterone levels to confirm they’re in the target range, hematocrit to catch blood thickening early, and PSA to watch for prostate changes. Without this ongoing lab work, even a legitimate prescription becomes a gamble. The risks of testosterone therapy are real but largely manageable when they’re caught early through routine blood tests. The risks of unmonitored use, whether prescription or over-the-counter, are not.